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ABSTRACT 1 
Background: Deep brain stimulation (DBS) surgery is an option for patients experiencing 2 
medically resistant neurological symptoms. DBS complications are rare; finding significant predictors 3 
requires a large number of surgeries. Machine learning algorithms may be used to effectively predict 4 
these outcomes. The aims of this study were to (1) investigate preoperative clinical risk factors, and (2) 5 
build machine learning models to predict adverse outcomes. 6 
Methods: This multicenter registry collected clinical and demographic characteristics of patients 7 
undergoing DBS surgery (n=501) and tabulated occurrence of complications. Logistic regression was 8 
used to evaluate risk factors. Supervised learning algorithms were trained and validated on 70% and 9 
30%, respectively, of both oversampled and original registry data. Performance was evaluated using 10 
area under the receiver operating characteristics curve (AUC), sensitivity, specificity and accuracy. 11 
Results: Logistic regression showed that the risk of complication was related to the operating 12 
institution in which the surgery was performed (OR=0.44, confidence interval [CI]=0.25-0.78), BMI 13 
(OR=0.94,CI=0.89-0.99) and diabetes (OR=2.33,CI=1.18-4.60). Patients with diabetes were almost 14 
three times more likely to return to the operating room (OR=2.78,CI=1.31-5.88). Patients with a history 15 
of smoking were four times more likely to experienc postoperative infection (OR=4.20,CI=1.21-16 
14.61). Supervised learning algorithms demonstrated high discrimination performance when predicting 17 
any complication (AUC=0.86), a complication within 12 months (AUC=0.91), return to the operating 18 
room (AUC=0.88) and infection (AUC=0.97). Age, BMI, procedure side, gender and a diagnosis of 19 
Parkinson’s disease were influential features. 20 
Conclusions: Multiple significant complication risk factors were identified and supervised learning 21 
algorithms effectively predicted adverse outcomes in DBS surgery.  22 
  23 
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INTRODUCTION 24 
The primary aim of this study was to look at which preoperative clinical factors were related to 25 
complications that develop in deep brain stimulation (DBS) therapy. DBS is a safe, effective and 26 
common surgical intervention for a range of neurological disorders including Parkinson’s disease and 27 
essential tremor 1–7. Through electrodes implanted in the brain, DBS therapy stimulates deep subcortical 28 
brain structures, including the subthalamic nucleus (STN), the ventral intermedius nucleus (VIM) and 29 
the globus pallidus (GPi) to alleviate neurological symptoms like tremor, motor fluctuations, and 30 
rigidity 4,5,8. It is a treatment modality that is considered when a patient’s symptoms have not been 31 
satisfactorily alleviated by medical management 9–14.32 
DBS therapy requires an initial electrode implantation operation and subsequent surgery to place 33 
device generators. Potential complications arising from DBS surgery include infection, intracerebral 34 
hemorrhage, seizures and hardware failure, which can le d to unplanned return to the operating room. 35 
Post-operative readmission rates range from 1.9% (30-day) to 4.3% (90-day) 1. Factors likely associated 36 
with complications include age, smoking history, obesity, diabetes, hypertension and facility surgical 37 
volume 1,15.  Advanced age and hypertension have been associated wi h the risk of intracranial 38 
hemorrhage 16,  and readmission after DBS surgery has been associ ted with preoperative coronary 39 
artery disease, obesity and a history of smoking 1. Further, there is a seasonal variation in DBS 40 
infection, often referred to as the July effect 17.   41 
Integrating preoperative risk assessment into standard clinical care fosters a shared decision making 42 
process between the surgical team, the patient and clinical enablers 18.  Performing pre-operative risk 43 
assessment for DBS procedures is challenging due to limited data suggesting the contributions of 44 
individual risk factors to post-operative complicatons. It is arguable that the literature surrounding 45 
DBS surgery risk remains inconclusive because the low frequency of complications limits the power 46 
and sensitivity of traditional statistical methods. To study this problem, a multi-institutional database of 47 
complications and risk factors was compiled, and a pilot study analysed it. Similar to the literature, the 48 
only relationship found was an association between smoking and infection risk. The standard statistical 49 
methods applied were ineffective at determining significant clinical risk factors related to 50 
complications, such as body mass index, diabetes, hypertension, smoking, and age. So, a different 51 
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approach to identifying relationships between complications and risk factors, involving the use of 52 
machine learning, was designed and deployed.  53 
Machine learning, a branch of artificial intelligence, represents a powerful set of technologies that 54 
enable three main tasks: classification, regression and clustering 19. Supervised learning involves 55 
training algorithms with datasets that contain labelled outcomes for each case. Supervised learning (i.e.,56 
classification and regression) uses input features (X) to predict a defined outcome (Y), while 57 
unsupervised learning (i.e., clustering) involves analyzing input variables (X) to elucidate patterns a d 58 
structure in the data. Supervised learning algorithms can predict rare events such as surgical 59 
complications 20 and have the potential to improve patient risk stratification, clinical decision making, 60 
informed consent and health service planning 18,21–25. Supervised learning has been used in DBS surgery 61 
to predict clinical outcomes 26,27, surgical targets 28,29, side effects 30, discharge status 31 and 62 
neurophysiological detection of DBS structures 32–34.  63 
Extreme gradient boosting machines (XGBM) are a type of supervised learning algorithm. It uses 64 
decision tree-based learning and shows strong performance on a diverse array of problems. It operates 65 
by strategically combining networks of sequential decision trees. Later decision tree models correct 66 
inaccuracies in previous models to improve prediction performance 35. An XGBM model is comprised 67 
of an ensemble of decision trees. The development of alg rithms that incorporate gradient boosting has 68 
produced highly robust regression and classification methods 36. XGBMs appear to have performed 69 
well in various domains 35,37–41 and have been shown to perform particularly well on datasets 70 
characterized by class imbalance 42,43. Many supervised learning algorithms perform well as predictive 71 
tools partly because they can estimate complex nonlinear relationships in high volume datasets using 72 
weighted statistical functions in a way that cannot be perceived by linear models or clinicians 44–47. 73 
Logistic regression is one such linear classification model. Two advantages it affords are that it is ea ily 74 
interpretable, and it delivers measures of statistical significance.  75 
Class imbalance describes a situation where the number of one event type (e.g., postoperative DBS 76 
complications) is very low compared to another event type (e.g., no postoperative DBS complications) 77 
48. A class is a subcategory within a variable in a dataset. For example, within a variable capturing data 78 
on postoperative complications, one class may repres nt the complication state, while another class may 79 
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represent the no-complication state. Class imbalance essentially refers to differences in class 80 
probabilities 49. Postoperative DBS complications are low probability events. There is a much higher 81 
probability that DBS patients will experience no postoperative complications. This imbalanced outcome 82 
probability is what is meant by researchers referring to imbalanced classes. Chawla (2010) states that a 83 
dataset is imbalanced if the classification categori s are not equally represented 50. The performance of 84 
some supervised learning algorithms is undermined by class imbalance, resulting in output 85 
classifications that default simply to the majority class 51–53 . However, class imbalance characterizes 86 
many real-world datasets from biomedicine 52, to finance 54, aviation 55 and geoscience 56. Class 87 
imbalance is one of the main barriers to effectively predicting postoperative complications in 88 
neurosurgery 18,19,24,31.  89 
Because the class imbalance problem is so prevalent 53, much research in the fields of predictive 90 
analytics, data mining and machine learning has focused on developing and testing methods to 91 
effectively address it, at both the algorithm and data levels 49,51,52,57–59. The Synthetic Minority 92 
Oversampling Technique (SMOTE) has emerged as one effective method of addressing the class 93 
imbalance issue at the data level 59. It operates by creating additional synthetic cases based upon 94 
existing minority cases and the k-nearest neighbor algorithm. It balances the class distribution by 95 
synthesizing new additional minority class examples through a process of interpolating between 96 
multiple minority class examples that lie together in multidimensional space. In this way, SMOTE has 97 
been intentionally designed to avoid the predictive analytics problem of overfitting 53. Another strength 98 
of employing the SMOTE method is that no cases in the dataset need to be excluded from the predictive 99 
analysis, which is particularly useful in neurosurgery where cases are not common and datasets are 100 
often not large (i.e., hundreds of cases rather than t ousands). The application of SMOTE may 101 
effectively facilitate the prediction of DBS complications, which would be of substantial utility to 102 
clinicians.  103 
This study sought to answer the following two research questions. Can multivariate logistic 104 
regression detect significant associations between pr operative variables and postoperative outcomes? 105 




This study was approved by Institutional Review Boards at each study site. Due to the retrospective 109 
nature of the study, the requirement for informed consent was waived. A combined registry was created 110 
comprising 501 adults who underwent initial DBS implantation surgeries between October 1997 and 111 
May 2018 at two private practices. Procedures included were performed by five neurosurgeons at two 112 
neurosurgical centers over a 22-year period. Patients u derwent DBS implantation for Parkinson’s 113 
disease (n=348), essential tremor (n=129), dystonia (n=11) and other indications (n=13). 114 
Surgical Technique  115 
The general surgical technique was relatively similar among all surgeons. Primary surgeons at each 116 
institution each had >15 years of experience in DBS surgery. A frame-based approach was used in 117 
patients with DBS lead placement (unilateral or bilateral) using Medtronic 3389 or 3379 leads.  118 
Microelectrode recording was used in all cases. A single microelectrode was used to identify and 119 
confirm the target in all cases. The average number of microelectrode passes per lead was 1.4. 120 
Intraoperative imaging of lead location with cone beam CT was performed in some cases beginning in 121 
2008. The majority of patients underwent intraoperative bipolar review of clinical efficacy and side 122 
effects in an “awake” state 60. Generator placement was staged one to two weeks after initial lead 123 
implantation. All patients underwent postoperative MRI and/or CT scans within a week of lead 124 
implantation.   125 
Data 126 
Pre-existing quality assurance databases of DBS patients and their outcomes from both research 127 
sites were combined. Additional retrospective data were collected from electronic medical records. 128 
Potential risk factors were recorded, including age, gender, BMI, clinical diagnosis, smoking history, 129 
immunosuppression, hypertension (medications taken within 90 days of surgery), diagnosis of diabetes 130 
mellitus, hypertension, surgical target (VIM, STN, GPi) and procedure side (left, right, bilateral).   131 
Complication categories were intracranial hemorrhage, readmission, ischemic infarction, seizure, 132 
lead fracture, electrode migration, loose or flipping battery needing surgical revision, device 133 
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malfunction, return to the operating room and infection. An infection was defined as an event requiring 134 
surgical removal of hardware, regardless of the time after implantation. This included perioperative 135 
infections within 3 months of surgery, as well as delayed infection associated with hardware erosion or 136 
other systemic infections and infections after generator replacement surgery that could have been years 137 
later. Intracranial hemorrhage was defined as any form of new post-operative bleeding on radiology 138 
report, with or without neurological sequelae and not necessarily requiring surgical intervention. Return 139 
to the operating room included all surgeries that required a return to the operating room, regardless of 140 
time since lead implantation, for indications including haemorrhage, infection, erosion of hardware, 141 
fracture of hardware detected on imaging or as open circuit on programming, revision of lead location, 142 
revision of flipping or loose generator, or tight extension wires. Four primary outcomes were recorded 143 
for each patient: any postoperative complication, a complication within 12 months of surgery, return to 144 
the operating room and infection. 145 
Analysis 146 
Unilateral (n=151), simultaneous bilateral (n=296) and staged bilateral lead implantation (n=54) 147 
were counted each as a single case. Descriptive statistics, multivariate logistic regression and 148 
supervised learning model development were performed using Python 3.6. 149 
Neural network development for BMI data imputation  150 
Missing data can create problems for some supervised learning algorithms and may necessitate 151 
dropping entire cases. Further, missing data can adversely affect the validity of results 61. Out of 501 152 
cases, there were 51 missing BMI values. Given the scarce nature of DBS case data and the resources 153 
required to collect it, the research team was motivated to retain as many cases as possible for analysis. 154 
Data imputation addresses this issue and various methods can be used 61–65. Four neural network 155 
regression models were developed to impute BMI for the cases with missing data. BMI values were 156 
imputed using all pre- and post-operative variables in the dataset. One neural network was selected for 157 
imputation regression because it demonstrated the best performance. Mean BMI before and after 158 
imputation did not differ significantly (27.57, SD=5.06 and 27.39, SD=5.98, respectively; p=0.58).  159 
Feature selection 160 
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Three criteria were used when selecting input featur s for the models: (1) existing evidence in the 161 
literature suggesting a relationship between the featur  and the outcome, (2) availability of the feature 162 
in the dataset; and (3) clinical expert approval tht e feature under consideration was clinically re ated 163 
to the outcome variable. 164 
Multivariate logistic regression to detect associations 165 
Multivariate logistic regression was conducted using the statsmodels [53] and scikitlearn [54] 166 
packages. Multivariate model performance, odds ratios (OR) and confidence intervals (CI) were 167 
calculated for each risk factor. Features with negligible statistical contribution to multivariate models 168 
(z-score <0.02) were excluded and models were subseq ently retrained. 169 
XGBM model development for postoperative complication prediction 170 
Multiple classifiers were tested and compared to predict postoperative complication outcomes, 171 
including logistic regression, random forests, decision trees and support vector machines. Algorithm 172 
performance statistics were compared using multiple m trics including area under the receiver 173 
operating characteristic curve (AUC), accuracy, sensitivity, specificity, positive predictive value and 174 
negative predictive value. XGBM was among the highest performing classifiers. Because of this and 175 
previous literature demonstrating strong performance on imbalanced datasets, multiple XGBM models 176 
were developed using the XGBoost 66 package. For each of the four primary outcome variables, three 177 
XGBM models were created: one using the original dataset, one using the SMOTE dataset 59, and one 178 
using a SMOTE training dataset with a non-SMOTE validation dataset.  179 
Each model was trained on a 70% sample of the dataset and validated on the remaining 30%. In the 180 
original dataset, this resulted in 350 training cases and 151 validation cases. In the SMOTE 181 
oversampled datasets, ratios of training:validation case numbers were as follows: any complication, 182 
585:251; complication within 12 months, 618:266; retu n to the operating room, 627:269; and infection, 183 
663:285. SMOTE was selected over other techniques to address class imbalance because (1) it allowed 184 
retention and use of all cases in the DBS dataset, (2) it was designed to avoid overfitting, and (3) it has 185 
been implemented as an accessible Python package. 186 
 8
Hyperparameter tuning involving grid-search with 5-fold cross-validation was used to find optimal 187 
XGBM parameters. Grid-search employed 1512 hyperparameter combinations, resulting in 7560 fit 188 
cycles for each of the XGBM models. Using the optimal hyperparameters found in the grid-search 189 
process, internal cross-validation was conducted with the number of boosting rounds set at 50 and the 190 
number of early stopping rounds set at 10. AUC was used as the performance metric in this process.  191 
Predictions were made using the optimized model and the validation test sets. Confusion matrices 192 
and performance statistics were computed. Performance metrics included AUC, accuracy, sensitivity, 193 
specificity, positive predictive value and negative predictive value 44,67,68. Feature importance was 194 
calculated, decision trees were visualized and receiv r operating characteristics (ROC) curves 195 
developed. Figure 1 outlines the analysis process overall. 196 
  197 
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RESULTS 198 
Descriptive statistics are displayed in Table 1. Mean age at implant was 64±10.3 years.  The 199 
majority of patients were male (63%), were diagnosed with Parkinson’s disease (70%), had a BMI of 200 
25 or more (67%) and underwent a simultaneous bilateral (59%) STN procedure (70%). Patient 201 
characteristics did not differ significantly between institutions. 202 
Complication Rates 203 
There were 27 (5.4%) infections over the period of observation (mean 455 days). These infections 204 
were either perioperative, occurring within 3 months of lead implantation in 13 (2.6%) patients, or 205 
delayed in 14 (2.8%) patients. The median time to onset of all infections was 3.3 months. Delayed 206 
infections were typically related to hardware erosion, systemic infections, generator replacement, or 207 
appeared spontaneously. 208 
Surgical revision of hardware occurred in 26 (5.2%) patients, on average 28 months after initial 209 
implantation. These revisions were for lead or extension wire fracture in 18 (3.6%) patients, loose 210 
hardware in seven (1.4%), or repositioned leads due to side effects or poor efficacy in eight (1.6%).  211 
Intracranial hemorrhage occurred in 15 (3.0%) patients, all associated with lead implantation. This 212 
included intraparenchymal hemorrhage along the leadand subdural hematoma. No deaths occurred in 213 
any of these cases. Of these hemorrhages, 2 of 501 patients (0.4%) had substantial morbidity requiring 214 
surgical intervention. Other hemorrhages, 13 (2.6%), were observed on imaging, and resolved without 215 
surgical treatment or neurological sequelae. 216 
Risk factors identified using logistic regression 217 
Logistic regression demonstrated statistically significant relationships between risk factors and 218 
complications (Table 2). Diabetic patients were nearly three times more likely to return to the operating 219 
room than those without diabetes (OR=2.78, CI=1.31-5.88, p<0.01). Postoperative infection was 220 
associated with a history of smoking (OR=4.20, CI=1.21-14.61, p<0.05). It appeared that patients with 221 
a history of smoking were more than four times more lik ly to experience postoperative infection. 222 
Experiencing any type of complication was associated with operating institution (OR=0.44, CI=0.25-223 
0.78, p<0.01), BMI (OR=0.94, CI=0.89-0.99, p<0.05) and diabetes (OR=2.33, CI=1.18-4.60, p<0.05). 224 
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Operating institution was also significantly associated with experiencing a complication within 12 225 
months (OR=0.36, CI=0.18-0.70, p<0.01). The institution with slightly higher complication rates 226 
appeared to have operated on a patient sample with higher comorbidity rates (Table 3).  227 
Complication prediction with XGBM models 228 
XGBM models coupled with the SMOTE dataset demonstrated strong predictive performance 229 
(Table 4). These models demonstrated higher performance (validation AUC: 0.86-0.97) compared to 230 
models trained and validated on the original dataset (validation AUC: 0.57-0.69). Models based on the 231 
SMOTE dataset predicted high numbers of true positives and true negatives. Models trained on the 232 
SMOTE training dataset and validated on the non-SMOTE holdout sample demonstrated performance 233 
that was not substantially superior to the models trained on the original dataset.  234 
ROC curves were generated by running the trained moels on the holdout validation datasets. The 235 
ROC curves and corresponding AUC associated with the four SMOTE XGBM models showed strong 236 
performance (Figure 2). 237 
Plotting feature importance  238 
Feature importance metrics were plotted for each of the SMOTE XGBM models (Figure 3). Age, 239 
BMI, procedure side, gender, a diagnosis of Parkinson’s disease, institution and comorbidities appeared 240 
to be the most influential predictive features associated with complications. Feature importance 241 
appeared to vary slightly by model. When plotting complicated cases in the original dataset according 242 
to BMI and age, cases clustered at approximately age 70 and a BMI of 24 (Figure 4).  243 
Carrying out predictions on hypothetical patient data 244 
A set of hypothetical patients is shown to demonstrate the output of the XGBM predictive models 245 
(Table 5). Risk thresholds similar to those developd in cardiology risk stratification research were 246 
applied to facilitate interpretation of model output (low=<10%, moderate=10-15%, high=16-50%, very 247 
high= >50%) 69.  248 
  249 
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DISCUSSION 250 
This study found multiple clinical predictors of complications in DBS surgery using supervised 251 
machine learning algorithms. Logistic regression showed that patient BMI, diabetes and operating 252 
institution were significantly associated with all complications grouped together. Diabetics were almost 253 
three times more likely to return to the operating room. A history of smoking was significantly 254 
associated with postoperative infection. 255 
The XGBM supervised learning algorithm demonstrated strong predictive performance. The results 256 
of this study suggested that XGBMs, coupled with a SMOTE oversampling method, may be employed 257 
to successfully overcome the class imbalance problem and effectively predict complication outcomes in 258 
DBS surgery. This method may be used to estimate any individual patient’s risk of complications. 259 
Plotting feature importance demonstrated that age, BMI, gender, procedure side, a diagnosis of 260 
Parkinson’s disease, the operating institution and preoperative comorbidities were influential predictors 261 
of postoperative complications. The results of this study that suggested associations between 262 
preoperative risk factors and postoperative adverse outcomes are supported by previous research 263 
demonstrating that many of these same factors are significantly associated with complication outcomes 264 
in DBS surgery 31,70,71 and in other forms of neurosurgery 18,23,24,72,73.  265 
Surgeons often perceive patterns in their clinical practice. Machine learning algorithms seem to 266 
approximate well the intuition of the surgeon. Postoperative complications are likely to arise as a result 267 
of complex interactions between many risk factors 74. While logistic regression has been deployed in 268 
the past to predict surgical outcomes 18,24, other supervised learning algorithms, including XGBM, may 269 
be better suited to modeling these complex nonlinear rel tionships 44,48,75.  270 
This study has demonstrated one potential approach to addressing the class imbalance problem, 271 
which is a major issue in surgical risk stratificaton 18,19,24,31. The approach employed here, applying 272 
SMOTE oversampling in conjunction with the XGBM supervised learning algorithm, produced 273 
encouraging results.  274 
Simple linear relationships between risks and outcomes are intuitive. Linear and logistic regression 275 
generate statistical weights associated with each predictor and can be represented with a linear equation.  276 
These approaches offer rapid interpretability and a impression of understandability. In contrast, 277 
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advanced supervised machine learning algorithms are often more complex, inscrutable and opaque. 278 
Surgeons are likely to have a lower level of trust in, and therefore may demonstrate weaker adoption of, 279 
opaque machine learning algorithms as decision support tools. The XGBM performance statistics, 280 
feature importance plots and hypothetical cases generated help to address this issue by providing some 281 
insight into the mechanics of the XGBM models develop d. More work on developing the 282 
“explainability” of these models is required. 283 
A collection of hypothetical cases was presented to emonstrate the risk stratification outputs of the 284 
supervised learning models developed. There may be a tendency to attempt to identify patterns in the 285 
hypothetical patient data displayed and the corresponding risk evaluation output statistics. However, 286 
this tendency is fraught because the number of hypot etical cases displayed is small and the algorithms 287 
are able to model complex nonlinearities in the data, based on hundreds of training cases, which are 288 
likely to evade human judgement. Similar to previous research 18, these examples provide a random 289 
selection of cases and patient characteristics to offer clinicians a general sense of the predictive risk290 
outputs of the models trained. They are not intended to offer a systematic demonstration of the complex 291 
relationships modeled by the trained algorithms. 292 
These machine learning models have the potential to f cilitate patient safety improvements 76. They 293 
may be used to stimulate a deeper conversation about complications with a patient prior to surgery, 294 
more attention throughout the process from the surgeon and surgical team, closer patient follow-up and 295 
activation of other organizational patient support processes postoperatively. Models of this nature 296 
should form part of a broader comprehensive approach to clinical risk stratification and patient safety 297 
improvement. As an example from another domain of neurosurgery, the Seattle Spine Team has 298 
developed a systematic and standardised approach tht incorporates multidisciplinary patient review 299 
conferences, specialized clinical teams, intraoperative monitoring protocols and multi-surgeon 300 
operating practices, in addition to the development of experimental decision support systems 301 
underpinned by machine learning methods 24,77–84. 302 
The advantages of using machine learning methods to stratify risk in neurosurgery are numerous. 303 
Machine learning methods are more capable of capturing complex nonlinearities in very large datasets 304 
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than traditional statistical techniques and can be deployed to production using cloud computing services 305 
for potential use by clinicians and patients globally 85,86. These tools are well-suited to high-volume 306 
complex data processing, they facilitate access to inf rmation, they save time and they have the 307 
potential to augment the clinical functioning of the neurosurgeon. Incorporating machine learning tools 308 
into the neurosurgical workflow may assist in reducing the likelihood of clinical error and positively 309 
engaging the patient. Supervised machine learning models can provide accurate and individualized 310 
outcome predictions, which are likely to be beneficial as healthcare progresses toward a future that is 311 
more precise and value based. Prediction datapoints may feed into and influence perioperative care 312 
processes and decisions or intraoperative treatment by human and robotic systems. On the other hand, it 313 
may not be suitable to apply machine learning methods t  datasets that are erroneous, exceedingly 314 
noisy, obsolete or biased. In these cases, it may be preferable to rely on the unassisted judgment of the 315 
expert surgeon and an experienced clinical team.  316 
Limitations and future research 317 
The performance metrics using SMOTE oversampling and extreme gradient boosting were strong. 318 
Such high performance of the XGBM algorithms suggests that some degree of overfitting may have 319 
occurred, despite built-in overfitting mitigation. This, however, is difficult to assess, particularly in the 320 
context of limited case data. Caution and appropriate clinical judgement should be exercised if 321 
deploying and using these models to make predictions on new patient data. Further validation on new 322 
data from other institutions and larger datasets would be beneficial. 323 
While assessing the effects of the use of intraoperative CT on complication rates and patient 324 
outcomes was beyond the scope of this study, it may have been beneficial to control for its use in the 325 
analysis. Per patient labelling of this variable was not captured in the dataset and this is therefore a 326 
limitation of this study. Similarly, it would be ben ficial for future predictive modeling studies to 327 
control for additional preoperative clinical variables in multivariate analyses. These may include pre-328 
and post-operative functional status, anemia, operating time, the number of electrode passes, passage 329 
through the ventricle and a patient history of coronary artery disease or stroke. 330 
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A primary aim of this study was to develop models capable of stratifying patient complication risk 331 
in DBS surgery. To achieve this and to mitigate thelimitations of the dataset, complication 332 
subcategories were amalgamated into a superordinate variable representing general clinical risk and 333 
adverse outcomes. This approach allowed the developm nt of a set of useful and applicable models. 334 
However, it must be noted that these models are broad in their risk predictions and that to predict 335 
specific types of complications, which would enable th  implementation of specific clinical risk 336 
mitigation tactics (e.g., augmented infection prevention or operating room preparation for a returning 337 
patient), larger datasets and more modeling work are required. The variables included in the 338 
superordinate complication outcome variable fall logically under the banner of adverse postoperative 339 
clinical events. While the specific outcomes that make up this variable may be considered diverse, 340 
amalgamating them remains clinically useful because tog ther they broadly indicate high risk patients 341 
that may require additional critical clinical thought and discussion, resources and careful perioperativ  342 
management. 343 
Future research may deploy the methods applied here for the prediction of complications associated 344 
with other surgical procedures that are characterized by a similar class imbalance problem. Studies may 345 
also develop supervised learning models to predict positive functional outcomes and the degree of 346 
functional improvement associated with various neuros gical procedures. Future work may focus on 347 
the development of clinical decision support system to be applied in clinical practice and to deliver 348 
decision-support benefits directly to patients via application to patient consultations in the clinics 87.   349 
Conclusion 350 
Significant complication risk factors were detected and supervised machine learning algorithms 351 
effectively predicted adverse outcomes in DBS surgery. These supervised learning models can be used 352 
for the improvement of risk stratification, preoperative patient informed consent and clinical planning 353 
to make DBS surgery safer for patients. XGBMs and SMOTE appear to be useful tools for the 354 
prediction of complication outcomes and risk stratification in DBS surgical practice.  355 
  356 
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Figure legend:  
• Figure 1: Schematic outline of the two main phases of the analysis process. 
• Figure 2: ROC curves for each of the SMOTE XGBM models, derived from the holdout test validation 
datasets.  
• Figure 3: Feature importance plots for each of the SMOTE XGBM models. BMI = body mass index. DM 
diabetes mellitus. GPi = globus pallidus. HB = hemiballismus. HTN = hypertension. L = left. PD = 
Parkinson’s Disease. R = right. STN = subthalamic nu leus. VIM = ventral intermedius nucleus. 
• Figure 4: Joint plots of complicated cases (any complication; A) and uncomplicated cases (B) in our 
sample according to age and BMI. Complicated cases clustered at approximately age=70 and BMI=24, 
whereas uncomplicated cases clustered at approximately ge=69 and BMI=28. Histograms plot age and 
BMI frequency distributions. 
Feature Category Feature Feature class Count (%)  
Predictors Institution Institution 1  201 (40%) 
Institution 2  300 (60%) 
Age 75 and over  70 (14%) 
Under 75 431 (86%) 
Gender Male 318 (63%) 
Female 183 (37%) 
Diagnoses Parkinson’s disease 349 (70%) 
Essential tremor 129 (26%) 
Dystonia 11 (2%) 
Other 12 (2%) 
BMI ≥25 335 (67%) 
18 to 24.9 157 (31%) 
<18 9 (2%) 
Comorbidities and risk factors Smoking history 25 (5%) 
Immune suppressed 25 (5%) 
Diabetes 67 (13%) 
Hypertension 231 (46%) 
Procedure type Subthalamic (STN) 349 (70%) 
Thalamic (VIM) 128 (26%) 
Globus pallidus internus (GPi) 22 (4%) 
Other 2 (0%) 
Outcomes Intracranial hemorrhage 15 (3%) 
Readmission 17 (3%) 
Ischemic infarction 3 (1%) 
Seizure 3 (1%) 
Lead fractures 18 (4%) 
Electrode migration 8 (2%) 
Battery loose or flipping 7 (1%) 
Device malfunction 26 (5%) 
Return to operating room 53 (11%) 
Infection 27 (5%) 
Hemiparesis 5 (1%) 
Facial droop 6 (1%) 
Sensory change 4 (1%) 
Complication other 8 (2%) 
Complication any 83 (17%) 
Complication within 12 months 59 (12%) 
 
Table 1: Descriptive statistics displaying the classes of each of the predictors and outcome features in the 
dataset of 501 DBS patients. Other diagnoses included cluster headache, Holmes tremor and Tourette 
Syndrome.  
 
  Any complication  Complication within 12 months Return to the operating room Infection 
  Coefficient OR (95% CI) Coefficient OR (95% CI) Coefficient OR (95% CI) Coefficient OR (95% CI) 
Intercept 0.35 1.55  
(0.35, 6.90) 
-0.60 0.55  
(0.10, 3.00) 
-0.79 0.46  
(0.08, 2.67) 












Institution 02 -0.82** 0.44  
(0.25, 0.78) 
-1.03** 0.36  
(0.18, 0.70) 
-0.39 0.68  
(0.35, 1.34) 
-- -- 




0.17 1.18  
(0.50, 2.80) 
0.90 2.45  
(0.88, 6.78) 




-0.09 0.91  
(0.50, 1.68) 
0.13 1.14  
(0.48, 2.68) 




-0.04 0.96  
(0.90, 1.02) 

















1.02** 2.78  
(1.31, 5.88) 
0.56 1.75  
(0.58, 5.29) 




-0.18 0.84  
(0.43, 1.60) 
0.83 2.29  
(0.99, 5.30) 






1.44* 4.20  
(1.21, 14.61) 




-1.30 0.27  
(0.03, 2.27) 
-- -- 






-0.45 0.64  
(0.07, 5.96) 
Dystonia -1.02 0.36 
(0.03, 4.12) 
-- -- -0.53 0.59  
(0.05, 7.25) 
-- -- 
Diagnosis other -0.59 0.55 
(0.07, 4.17) 
-- -- -- -- -- -- 




0.37 1.44  
(0.28, 7.55) 








0.60 1.82  
(0.39, 8.51) 
0.10 1.10  
(0.21, 5.70) 














-0.52 0.59  
(0.20, 1.75) 
0.32 1.37  
(0.41, 4.62) 
LLR p-value p=0.09 p<0.05 p=0.54 p=0.21 
 
Table 2: Multivariate logistic regression modelling results. These results are based on analysis of the original (non-
SMOTE) dataset. CI = confidence interval. LLR = loglikelihood ratio. OR = odds ratio. The reference categories 
were: female, Parkinson’s Disease, age <75, institution 01, an operation conducted on both sides and a STN 






 Institution 01 Institution 02 
Number of cases 201 300 
Demographics Age (mean, SD) 62.12 (10.52) 66.28 (9.94) 
BMI (mean, SD) 27.71 (5.47) 27.17 (4.62) 
Female 41% 34% 
Diagnosis Parkinson’s disease 68% 71% 
Essential tremor  24% 27% 
Dystonia  1% 3% 
Clinical features Smoking history  5% 5% 
Immune suppressed  9% 2% 
Diabetes mellitus  13% 13% 
Hypertension  70% 30% 
Target STN  69% 70% 
VIM  27% 24% 
GPi  3% 5% 
Procedure side Left  36% 25% 
Right  17% 8% 
Both  47% 67% 
Complication outcomes Any complication  22% 13% 
Complication at 12 months  18% 7% 
Return to the operating room  11% 10% 
Infection  6% 5% 
 
Table 3: A comparison of case characteristics between institutions, demonstrating a notable difference in the 
prevalence of patients with hypertension and immune suppression.  
 
 
















Performance on validation holdout datasets 
  Accuracy 0.66 0.86 0.88 0.95 0.85 0.91 0.88 0.97 
  AUC 0.58 0.69 0.57 0.68 0.94 0.96 0.97 0.99 
  Sensitivity 0.07 0.00 0.00 0.00 0.96 0.98 0.99 1.00 
  Specificity 0.81 0.88 0.91 0.95 0.78 0.85 0.80 0.93 
  PPV 0.08 0.00 0.00 0.00 0.75 0.85 0.77 0.93 
Confusion matrices 
Predicted Actual Actual 
+ - + - + - + - + - + - + - + - 
  + 2 23 0 18 0 13 0 8 99 33 120 21 108 32 134 10 
  - 29 97 3 130 5 133 0 143 4 115 3 122 1 128 0 141 
 
Table 4: Predictive performance metrics of XGBM models predicting (1) any complication, (2) complication within 12 months, (3) return to the operating room and (4) 
infection; using (a) the original dataset, and (b) the SMOTE oversampled training and validation datasets.  
 
 
 Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 Patient 7 Patient 8 Patient 9 Patient 10 
Institution 1 1 1 1 2 2 2 2 1 2 
Age at implant 33 48 63 75 33 48 54 78 57 76 
Gender F F M M M M F F M M 
BMI 18 24 30 27 28 35 22 29 35 40 
Diagnosis PD Dyst PD PD PD ET PD PD PD ET 
Smoking history No Yes No Yes Yes No Yes Yes Yes No 
Immunosuppression  Normal Normal Normal Yes Normal Normal Yes Normal Yes Normal 
Diabetes status -- DM -- -- -- DM -- DM DM DM 
Hypertension status -- -- HTN -- HTN -- -- HTN HTN -- 
Procedure target  STN GPi GPi STN STN VIM STN STN STN VIM 
Procedure side  Left Both Left Right Both Both Left Both Both Right 
























































































Table 5: Hypothetical patient characteristics and corresponding predicted complication likelihood. Risk 
thresholds are based on decision boundaries developed in cardiology: Low = <10%; Moderate = 10-15%; 
High = 16-50%; Very high = >50%. Dyst = dystonia. ET = essential tremor. GPi = globus pallidus. H = hig . 
L = low. M = moderate. PD = Parkinson’s Disease. STN = subthalamic nucleus. VH = very high. VIM = 
ventral intermedius nucleus.    
 
 
Phase 1: Statistical Analysis
Purpose: Detect hypothesis-driven statistically 
significant associations
Phase 2: Supervised Learning
Purpose: Train XGBM classifiers to enable complication prediction
Performance evaluation
AUC    ACC    SEN    SPC   PPV   NPV
XGBM   
Original dataset




70% training set 30% validation set
Original dataset
70% SMOTE 
training set 30% validation set
XGBM hyperparameter tuning
Training











Abbreviation Expansion / Meaning 
AUC  area under the receiver operating characteristics curve 
CI  confidence interval 
DBS deep brain stimulation 
Dyst  dystonia 
ET  essential tremor 
GBM  gradient boosting machine 
GPi  globus pallidus 
H  High 
L  Low  
LLR  log likelihood ratio  
M  Moderate  
NPV  negative predictive value 
OR  odds ratio 
PD  Parkinson’s disease 
PPV  positive predictive value 
ROC receiver operating characteristics  
SMOTE  Synthetic Minority Oversampling Technique   
STN  subthalamic nucleus 
VH  Very high 
VIM  ventral intermedius nucleus 
XGBM  extreme gradient boosting machine 
 
